help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-96-3-822
Endocrinology Vol. 96, No. 3 822-828
Copyright © 1975 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HAMPSHIRE, J.
Right arrow Articles by GREENE, L.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HAMPSHIRE, J.
Right arrow Articles by GREENE, L.J.

Radioimmunoassay of Canine Growth Hormone: Enzymatic Radioiodination1

J. HAMPSHIRE, N. ALTSZULER, R. STEELE2 and L.J. GREENE

The Department of Pharmacology Neio York University School of Medicine New York, New York 10016 The Biology Department, Brookhaven National Laboratory Upton, New York 11973

Abstract

A sensitive radioimmunoassay is described for the measurement of plasma concentrations of canine growth hormone (cGH) as low as 0.25 ng/ml. The assay utilizes enzymatically iodinated cGH and the double antibody technique. The mean plasma concentration of growth hormone in the normal dog after overnight fast is 1.75 ± .17 ng/ml. Exogenous cGH was cleared from the plasma of both the normal and hypophysectomized dog with a mean half-life of 25.6 ± 1.0 min and was distributed in a volume equal to 8.9% of the body weight. Insulin hypoglycemia produced a 3- to 5-fold increase in plasma GH in 4 of 6 dogs and arginine infusion failed to produce a statistically significant rise. (Endocrinology 96: 822, 1975)

Footnotes

1 Investigations carried out at New York University School of Medicine were supported by Research Grant AM 10188 from the National Institute of Arthritis and Metabolic Diseases and by Grant P-207 (H) from the American Cancer Society. Part of this research was carried out at Brookhaven National Laboratory under the auspices of the U.S. Atomic Energy Commission. A preliminary account of this work was presented during the 57th Annual meeting of the Federation of American Societies for Experimental Biology, Atlantic City, N.J., April, 1973.

2 Dr. Steele died during the course of this study, on Jan. 18, 1974. He was a devoted scientist and warm friend and we dedicate this presentation to his memory.

Received July 10, 1974.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1975 by The Endocrine Society